The Community

April 2007
Pharmaceutical Representative;Apr2007, Vol. 37 Issue 4, p48
The article announces that Kelly Chapa of Abbott Laboratories Inc. was appointed senior territory manager level 4 along with Linda Raub of AstraZeneca who was promoted to career ladder level 3 and Robert Sichinga of Boehringer Ingelheim who was named district manager from institutional specialist.


Related Articles

  • 2000 PERQ/HCI HEALTHCARE ADVERTISING REVIEW. May, Eugene M. // Medical Marketing & Media;Apr2001, Vol. 36 Issue 4, p66 

    Reports on the marketing performance of health specialty markets in the U.S. Growth in the ophthalmology market; Increase in the sales of the radiology market; Contribution of pharmaceutical industry.

  • BCPS for Dummies. BURTON, JULIANNA L. // California Journal of Health-System Pharmacy;Jul/Aug2013, Vol. 25 Issue 4, p128 

    A personal narrative is presented which explores the author's experience preparing and taking a Board Certifications exam through the Board of Pharmaceutical Specialties for its various designations and specialties including Ambulatory Care, Pharmacotherapy, and Oncology.

  • SfL looks to start new specialist skills groups.  // Commercial Motor;5/9/2013, Vol. 219 Issue 5534, p42 

    The article reports that Skills for Logistics (SfL) plans to launch occupational craft skills groups which focuses on waste operations and pharmaceutical.

  • Rapid growth of specialty meds a pharmacy opportunity, report says.  // Drug Store News;12/11/2006, Vol. 28 Issue 17, p3 

    The article reports on the affirmation by the National Association of Chain Drug Stores (NACDS), based in Alexandria, Virginia, that specialty pharmaceutical products will offer greater sales-growth opportunities to community pharmacy. Specialty products for the treatment of cancer, immune...

  • Teva to Acquire Cephalon in $6.8 Bln Transaction.  // Biomedical Market Newsletter;5/5/2011, p465 

    The article reports that Teva Pharmaceutical Industries Ltd. acquires Cephalon Inc. in 6.8 billion U.S. dollars definitive agreement with 81.5 U.S. dollars per share. It is stated that the combined company will focus in specialty pharmaceuticals including oncology, respiratory and pain...

  • Medicare cuts anger doctors. Garza, Xazmin // Las Vegas Business Press;8/2/2004, Vol. 21 Issue 29, p1 

    Reports on the sentiment among oncologists about the Medicare reforms in the U.S. Impact of the reduction in cancer drug reimbursement to the medical practice of the cancer specialists; Argument of the federal government about the difference between the discounted price the physicians pay and...

  • Five System Barriers to Achieving Ultrasafe Health Care. Amalberti, RenĂ©; Auroy, Yves; Berwick, Don; Barach, Paul // Annals of Internal Medicine;5/3/2005, Vol. 142 Issue 9, p756 

    Although debate continues over estimates of the amount of preventable medical harm that occurs in health care, there seems to be a consensus that health care is not as safe and reliable as it might be. It is often assumed that copying and adapting the success stories of nonmedical industries,...

  • Continous Professional Development And The Pharmaceutical Industry- Education Or Marketing? Rashid, A. R. A. // Bangladesh Journal of Medical Science;Jan2013, Vol. 12 Issue 1, p5 

    The author reflects on the significance of professional ethics in promoting and enhancing the behaviour of doctors or specialists in the pharmaceutical industry. It states that continuing education of doctors on ethical standards will facilitate maintenance of high ethical standard across the...

  • Pharmaceutical Medicine in Italy. Criscuolo, Domenico // Pharmaceutical Medicine - New Zealand;2010, Vol. 24 Issue 1, p15 

    Italy has a long-standing tradition in the pharmaceutical industry and this historical background is instrumental for a better understanding of the present scenario. Today, major pharmaceutical companies with headquarters outside Italy represent the vast majority of the drug sector; such...


Read the Article


Sign out of this library

Other Topics